Isis Pharmaceuticals Inc (NASDAQ:ISIS)

Wednesday’s Trading Day
70.16 +1.50 / +2.18%
As of Mar 04
Day’s Change
Thursday’s Pre-Market   Switch to standard view »
70.20 +0.04 / +0.06%
 
Volume: 3.3K
Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analy...
Mar 04 / Zacks.com
Company News for March 02, 2015 - Corporate Summary
Mar 02 / Zacks.com
Pfizer Inc. Has a Growth Problem -- Here Are 3 Ways to Change That
Mar 04 / MotleyFool.com
Isis Pharmaceuticals (ISIS) Is Today's Unusual Social Activity Stock
Mar 02 / TheStreet.com
Roche's Avastin Gets Positive Opinion for Cervical Cancer - Analyst Blog
Mar 02 / Zacks.com
Horizon Pharma Beats on Q4 Earnings, Lifts 2015 Guidance - Analyst Blog
Mar 02 / Zacks.com
Gilead's (GILD) HIV Drug Positive in 2 Phase III Studies - Analyst Blog
Mar 02 / Zacks.com
Benzinga's Top #PreMarket Losers
Mar 02 / Benzinga
Alexion's Soliris' Label May be Updated upon EC Approval - Analyst Blog
Mar 02 / Zacks.com
Whoa, a Profit for Isis Pharmaceuticals Inc.
Feb 28 / MotleyFool.com
Amgen's Kyprolis Fares Better than Velcade in Study - Analyst Blog
Mar 02 / Zacks.com
Isis Pharmaceuticals (ISIS) Reports Earnings: Itbs A Beat
Feb 27 / Investing Channel
Biogen/Sobi Report Postive Phase III Data on Alprolix - Analyst Blog
Mar 02 / Zacks.com
Earnings Scheduled For February 27, 2015
Feb 27 / Benzinga
Notable Downgrades: Navient (NAVI), Star Bulk Carriers (SBLK), China Mobile (CHL), TC...
Mar 02 / Investing Channel
Can Isis Pharmaceuticals (ISIS) Beat Earnings this Season? - Analyst Blog
Feb 25 / Zacks.com
Keryx Biopharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog
Mar 02 / Zacks.com
Will Celldex Therapeutics (CLDX) Disappoint This Earnings? - Analyst Blog
Feb 23 / Zacks.com
3 Stocks Dragging The Drugs Industry Downward
Mar 02 / TheStreet.com
Will BioMarin (BMRN) Beat Estimates this Earnings Season? - Analyst Blog
Feb 23 / Zacks.com
Isis Pharmaceuticals Up on Q4 Earnings and Revenues Beat - Analyst Blog
Mar 02 / Zacks.com
What's in Store for Endocyte (ECYT) this Earnings Season? - Analyst Blog
Feb 20 / Zacks.com
Morning Market Losers
Mar 02 / Benzinga
Will Express Scripts (ESRX) Beat Q4 Earnings Estimates? - Analyst Blog
Feb 20 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account